The global market for Drug Abuse Testing was valued at US$ 20390 million in the year 2024 and is projected to reach a revised size of US$ 31700 million by 2031, growing at a CAGR of 6.6% during the forecast period.

Drug Abuse Testing Market

Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Abuse Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Testing.

The Drug Abuse Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Abuse Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Abuse Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Abuse Testing Market Report

Report Metric	Details
Report Name	Drug Abuse Testing Market
Accounted market size in year	US$ 20390 million
Forecasted market size in 2031	US$ 31700 million
CAGR	6.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Random Testing Reasonable Testing Post accident Testing Follow-up Testing
Segment by Application	Schools and Educational Institutes Hospitals and Healthcare Units Government and Private Departments
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Beckman Coulter
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Abuse Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug Abuse Testing Market growing?

Ans: The Drug Abuse Testing Market witnessing a CAGR of 6.6% during the forecast period 2025-2031.

What is the Drug Abuse Testing Market size in 2031?

Ans: The Drug Abuse Testing Market size in 2031 will be US$ 31700 million.

Who are the main players in the Drug Abuse Testing Market report?

Ans: The main players in the Drug Abuse Testing Market are Biomedical Diagnostics, BioMerieux, Abbott, Bio-Rad, Dako, DiaSorin, Eiken, Fujirebio, Beckman Coulter

What are the Application segmentation covered in the Drug Abuse Testing Market report?

Ans: The Applications covered in the Drug Abuse Testing Market report are Schools and Educational Institutes, Hospitals and Healthcare Units, Government and Private Departments

What are the Type segmentation covered in the Drug Abuse Testing Market report?

Ans: The Types covered in the Drug Abuse Testing Market report are Random Testing, Reasonable Testing, Post accident Testing, Follow-up Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Abuse Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Random Testing

1.2.3 Reasonable Testing

1.2.4 Post accident Testing

1.2.5 Follow-up Testing

1.3 Market by Application

1.3.1 Global Drug Abuse Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Schools and Educational Institutes

1.3.3 Hospitals and Healthcare Units

1.3.4 Government and Private Departments

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug Abuse Testing Market Perspective (2020-2031)

2.2 Global Drug Abuse Testing Growth Trends by Region

2.2.1 Global Drug Abuse Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Abuse Testing Historic Market Size by Region (2020-2025)

2.2.3 Drug Abuse Testing Forecasted Market Size by Region (2026-2031)

2.3 Drug Abuse Testing Market Dynamics

2.3.1 Drug Abuse Testing Industry Trends

2.3.2 Drug Abuse Testing Market Drivers

2.3.3 Drug Abuse Testing Market Challenges

2.3.4 Drug Abuse Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Abuse Testing Players by Revenue

3.1.1 Global Top Drug Abuse Testing Players by Revenue (2020-2025)

3.1.2 Global Drug Abuse Testing Revenue Market Share by Players (2020-2025)

3.2 Global Drug Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Abuse Testing Revenue

3.4 Global Drug Abuse Testing Market Concentration Ratio

3.4.1 Global Drug Abuse Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Abuse Testing Revenue in 2024

3.5 Global Key Players of Drug Abuse Testing Head office and Area Served

3.6 Global Key Players of Drug Abuse Testing, Product and Application

3.7 Global Key Players of Drug Abuse Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Abuse Testing Breakdown Data by Type

4.1 Global Drug Abuse Testing Historic Market Size by Type (2020-2025)

4.2 Global Drug Abuse Testing Forecasted Market Size by Type (2026-2031)

5 Drug Abuse Testing Breakdown Data by Application

5.1 Global Drug Abuse Testing Historic Market Size by Application (2020-2025)

5.2 Global Drug Abuse Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Drug Abuse Testing Market Size (2020-2031)

6.2 North America Drug Abuse Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Abuse Testing Market Size by Country (2020-2025)

6.4 North America Drug Abuse Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Abuse Testing Market Size (2020-2031)

7.2 Europe Drug Abuse Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Abuse Testing Market Size by Country (2020-2025)

7.4 Europe Drug Abuse Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug Abuse Testing Market Size (2020-2031)

8.2 Asia-Pacific Drug Abuse Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Abuse Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Abuse Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug Abuse Testing Market Size (2020-2031)

9.2 Latin America Drug Abuse Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Abuse Testing Market Size by Country (2020-2025)

9.4 Latin America Drug Abuse Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Abuse Testing Market Size (2020-2031)

10.2 Middle East & Africa Drug Abuse Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Abuse Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Abuse Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biomedical Diagnostics

11.1.1 Biomedical Diagnostics Company Details

11.1.2 Biomedical Diagnostics Business Overview

11.1.3 Biomedical Diagnostics Drug Abuse Testing Introduction

11.1.4 Biomedical Diagnostics Revenue in Drug Abuse Testing Business (2020-2025)

11.1.5 Biomedical Diagnostics Recent Development

11.2 BioMerieux

11.2.1 BioMerieux Company Details

11.2.2 BioMerieux Business Overview

11.2.3 BioMerieux Drug Abuse Testing Introduction

11.2.4 BioMerieux Revenue in Drug Abuse Testing Business (2020-2025)

11.2.5 BioMerieux Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Drug Abuse Testing Introduction

11.3.4 Abbott Revenue in Drug Abuse Testing Business (2020-2025)

11.3.5 Abbott Recent Development

11.4 Bio-Rad

11.4.1 Bio-Rad Company Details

11.4.2 Bio-Rad Business Overview

11.4.3 Bio-Rad Drug Abuse Testing Introduction

11.4.4 Bio-Rad Revenue in Drug Abuse Testing Business (2020-2025)

11.4.5 Bio-Rad Recent Development

11.5 Dako

11.5.1 Dako Company Details

11.5.2 Dako Business Overview

11.5.3 Dako Drug Abuse Testing Introduction

11.5.4 Dako Revenue in Drug Abuse Testing Business (2020-2025)

11.5.5 Dako Recent Development

11.6 DiaSorin

11.6.1 DiaSorin Company Details

11.6.2 DiaSorin Business Overview

11.6.3 DiaSorin Drug Abuse Testing Introduction

11.6.4 DiaSorin Revenue in Drug Abuse Testing Business (2020-2025)

11.6.5 DiaSorin Recent Development

11.7 Eiken

11.7.1 Eiken Company Details

11.7.2 Eiken Business Overview

11.7.3 Eiken Drug Abuse Testing Introduction

11.7.4 Eiken Revenue in Drug Abuse Testing Business (2020-2025)

11.7.5 Eiken Recent Development

11.8 Fujirebio

11.8.1 Fujirebio Company Details

11.8.2 Fujirebio Business Overview

11.8.3 Fujirebio Drug Abuse Testing Introduction

11.8.4 Fujirebio Revenue in Drug Abuse Testing Business (2020-2025)

11.8.5 Fujirebio Recent Development

11.9 Beckman Coulter

11.9.1 Beckman Coulter Company Details

11.9.2 Beckman Coulter Business Overview

11.9.3 Beckman Coulter Drug Abuse Testing Introduction

11.9.4 Beckman Coulter Revenue in Drug Abuse Testing Business (2020-2025)

11.9.5 Beckman Coulter Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Biomedical Diagnostics

List of Tables

Table 1. Global Drug Abuse Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Random Testing

Table 3. Key Players of Reasonable Testing

Table 4. Key Players of Post accident Testing

Table 5. Key Players of Follow-up Testing

Table 6. Global Drug Abuse Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Drug Abuse Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Drug Abuse Testing Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Drug Abuse Testing Market Share by Region (2020-2025)

Table 10. Global Drug Abuse Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Drug Abuse Testing Market Share by Region (2026-2031)

Table 12. Drug Abuse Testing Market Trends

Table 13. Drug Abuse Testing Market Drivers

Table 14. Drug Abuse Testing Market Challenges

Table 15. Drug Abuse Testing Market Restraints

Table 16. Global Drug Abuse Testing Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Drug Abuse Testing Market Share by Players (2020-2025)

Table 18. Global Top Drug Abuse Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Testing as of 2024)

Table 19. Ranking of Global Top Drug Abuse Testing Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Drug Abuse Testing Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Drug Abuse Testing, Headquarters and Area Served

Table 22. Global Key Players of Drug Abuse Testing, Product and Application

Table 23. Global Key Players of Drug Abuse Testing, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drug Abuse Testing Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Drug Abuse Testing Revenue Market Share by Type (2020-2025)

Table 27. Global Drug Abuse Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Drug Abuse Testing Revenue Market Share by Type (2026-2031)

Table 29. Global Drug Abuse Testing Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Drug Abuse Testing Revenue Market Share by Application (2020-2025)

Table 31. Global Drug Abuse Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Drug Abuse Testing Revenue Market Share by Application (2026-2031)

Table 33. North America Drug Abuse Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Drug Abuse Testing Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Drug Abuse Testing Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Drug Abuse Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Drug Abuse Testing Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Drug Abuse Testing Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Drug Abuse Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Drug Abuse Testing Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Drug Abuse Testing Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Drug Abuse Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Drug Abuse Testing Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Drug Abuse Testing Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Drug Abuse Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Drug Abuse Testing Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Drug Abuse Testing Market Size by Country (2026-2031) & (US$ Million)

Table 48. Biomedical Diagnostics Company Details

Table 49. Biomedical Diagnostics Business Overview

Table 50. Biomedical Diagnostics Drug Abuse Testing Product

Table 51. Biomedical Diagnostics Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 52. Biomedical Diagnostics Recent Development

Table 53. BioMerieux Company Details

Table 54. BioMerieux Business Overview

Table 55. BioMerieux Drug Abuse Testing Product

Table 56. BioMerieux Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 57. BioMerieux Recent Development

Table 58. Abbott Company Details

Table 59. Abbott Business Overview

Table 60. Abbott Drug Abuse Testing Product

Table 61. Abbott Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. Bio-Rad Company Details

Table 64. Bio-Rad Business Overview

Table 65. Bio-Rad Drug Abuse Testing Product

Table 66. Bio-Rad Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 67. Bio-Rad Recent Development

Table 68. Dako Company Details

Table 69. Dako Business Overview

Table 70. Dako Drug Abuse Testing Product

Table 71. Dako Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 72. Dako Recent Development

Table 73. DiaSorin Company Details

Table 74. DiaSorin Business Overview

Table 75. DiaSorin Drug Abuse Testing Product

Table 76. DiaSorin Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 77. DiaSorin Recent Development

Table 78. Eiken Company Details

Table 79. Eiken Business Overview

Table 80. Eiken Drug Abuse Testing Product

Table 81. Eiken Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 82. Eiken Recent Development

Table 83. Fujirebio Company Details

Table 84. Fujirebio Business Overview

Table 85. Fujirebio Drug Abuse Testing Product

Table 86. Fujirebio Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 87. Fujirebio Recent Development

Table 88. Beckman Coulter Company Details

Table 89. Beckman Coulter Business Overview

Table 90. Beckman Coulter Drug Abuse Testing Product

Table 91. Beckman Coulter Revenue in Drug Abuse Testing Business (2020-2025) & (US$ Million)

Table 92. Beckman Coulter Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Drug Abuse Testing Picture

Figure 2. Global Drug Abuse Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Drug Abuse Testing Market Share by Type: 2024 VS 2031

Figure 4. Random Testing Features

Figure 5. Reasonable Testing Features

Figure 6. Post accident Testing Features

Figure 7. Follow-up Testing Features

Figure 8. Global Drug Abuse Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Drug Abuse Testing Market Share by Application: 2024 VS 2031

Figure 10. Schools and Educational Institutes Case Studies

Figure 11. Hospitals and Healthcare Units Case Studies

Figure 12. Government and Private Departments Case Studies

Figure 13. Drug Abuse Testing Report Years Considered

Figure 14. Global Drug Abuse Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Drug Abuse Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Drug Abuse Testing Market Share by Region: 2024 VS 2031

Figure 17. Global Drug Abuse Testing Market Share by Players in 2024

Figure 18. Global Top Drug Abuse Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Abuse Testing as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Drug Abuse Testing Revenue in 2024

Figure 20. North America Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Drug Abuse Testing Market Share by Country (2020-2031)

Figure 22. United States Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Drug Abuse Testing Market Share by Country (2020-2031)

Figure 26. Germany Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Drug Abuse Testing Market Share by Region (2020-2031)

Figure 34. China Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Drug Abuse Testing Market Share by Country (2020-2031)

Figure 42. Mexico Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Drug Abuse Testing Market Share by Country (2020-2031)

Figure 46. Turkey Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Drug Abuse Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Biomedical Diagnostics Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 50. BioMerieux Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 51. Abbott Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 52. Bio-Rad Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 53. Dako Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 54. DiaSorin Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 55. Eiken Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 56. Fujirebio Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 57. Beckman Coulter Revenue Growth Rate in Drug Abuse Testing Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions